Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-02-22 @ 7:25 AM
Study NCT ID:
NCT05194293
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-04
First Post:
2021-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
Sponsor:
Academic and Community Cancer Research United
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ACCRU-GI-1920
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |